Benefits of early antiretroviral therapy in HIV-infected children

July 26, 2018, Pasteur Institute

Without treatment, an HIV-infected child is at greater risk of disease progression to AIDS than an adult. Initiation of early treatment in infants shows an undeniable clinical benefit by reducing the risk of death in early childhood. It may also be accompanied by a significant reduction of the viral reservoir (the amount of total viral DNA present in the immune cells of patients), which could promote the accumulation of conditions required for remission. It is therefore essential to better understand the interactions between the virus and the immune systems of children, and more accurately evaluate the short and long-term virological and immunological benefits of initiation of early therapy in children. These are the objectives of an ANRS CLEAC study.

This physiopathological study included 46 children from five to 12 years old and 30 adolescents from 13 to 18 years old living with HIV since birth. Among them, 36 started antiretroviral therapy before the age of six months, and 40 after the age of two years. All achieved virologic success. Researchers examined participants' blood samples, defined their immunological and virological status and analysed the results according to their age at the time of the study and the age at which they started .

The ANRS CLEAC team assessed the viral reservoir and observed that the viral ADN level was significantly lower in children and adolescents who started their treatment before the age of six months compared with those who started treatment after the age of two years. This lower also persists in early treated adolescents, even though some of them take their medication less regularly.

In parallel, the immunological analysis looked at naïve T lymphocytes, which have the ability to respond to new pathogens and vaccines. The ANRS CLEAC team found that these were present in greater numbers in who started antiretroviral therapy before the age of six months. This difference was not observed in the adolescents. This higher level of naïve T lymphocytes is one of the markers of a healthy immune system.

Thus, the initial findings of the ANRS CLEAC study show that, for the first time, initiation of before the age of six months in HIV-infected infants has undeniable virological and immunological benefits, which are observed until late childhood, or even into adulthood.

Explore further: HIV: A therapeutic advance for resource-limited settings

Related Stories

HIV: A therapeutic advance for resource-limited settings

May 29, 2017
ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective ...

HIV: The benefits of prophylaxis of tuberculosis are confirmed

October 11, 2017
A long-term follow-up study in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries. This prophylactic use of drugs reduces mortality, ...

HIV remission—the quest to turn lessons from exceptional cases into solutions

November 8, 2017
The case of an HIV-infected child in South Africa who has been in remission for nearly nine years without taking any antiretroviral drugs has provided further proof that HIV remission is possible.

Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens

March 4, 2013
A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early ...

Rapid, successful response to ART for many patients with HIV

September 30, 2016
(HealthDay)—Many HIV-infected patients have rapid and successful immune and virological response to antiretroviral therapy (ART), according to a study published online Sept. 27 in the Journal of Clinical Pharmacy and Therapeutics.

Study supports use of short-term HIV treatment interruption in clinical trials

January 11, 2018
A short-term pause in HIV treatment during a carefully monitored clinical trial does not lead to lasting expansion of the HIV reservoir nor cause irreversible damage to the immune system, new findings suggest.

Recommended for you

New HIV therapy reduces virus, boosts immunity in drug-resistant patients

August 15, 2018
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy ...

In choosing care, HIV patients in Zambia prefer kindness over convenience

August 15, 2018
As a healthcare patient, what would you sacrifice for a provider with a nice—rather than rude—attitude? For HIV patients in Zambia, the answer may surprise you.

Details of HIV-1 structure open door for potential therapies

August 9, 2018
New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Researchers uncover potential new drug targets in the fight against HIV

August 7, 2018
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that ...

Naltrexone helps HIV positive individuals reduce heavy alcohol use

August 7, 2018
Extended-release naltrexone—an injection that decreases heavy drinking in the general population when taken in conjunction with counseling—appears to help HIV-positive individuals reduce their number of heavy drinking ...

EU door opens for generic version of AIDS medicine Truvada

July 26, 2018
Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.